Skip to main content

Advertisement

Table 3 Factors associated with treatment delay among bacteriologically confirmed TB patients who received treatment in 21 township health centres of the Mandalay Region of Myanmar between January and June 2017

From: Pre-treatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region, Myanmar

Variables Total (n) Treatment delay (n (%)) RR (95%CI) aRR (95% CI)
Total 940 46 (4.9)   
Age (years)
 < 15 3 0 (0.0)   
 15–44 536 18 (3.4) Ref Ref
 45–64 308 21 (6.8) 2.0 (1.1–3.8) 1.9 (1.0–3.6)
 ≥ 65 93 7 (7.5) 2.2 (0.9–5.2) 2.0 (0.8–4.9)
Gender
 Male 701 36 (5.1) Ref Ref
 Female 239 10 (4.2) 0.8 (0.4–1.6) 0.8 (0.4–1.8)
Phone number     
 Recorded 31 2 (6.5) 0.3 (0.0–2.2)  
 Not recorded 909 44 (4.8) Ref  
HIV status
 Positive 46 4 (8.7) 2.03 (0.7–5.5) 1.86 (0.6–5.4)
 Negative 864 37 (4.3) Ref Ref
 Unknown 30 5 (16.7) 3.89 (1.6–9.2) 3.76 (1.4–9.9)
History of TB treatment
 Yes 67 6 (8.9) 2.08 (0.9–4.9) 1.89 (0.7–4.8)
 No 630 27 (4.3) Ref Ref
 Unknown 243 13(5.4) 1.24 (0.6–2.4) 1.15 (0.6–2.3)
Sputum result
 Smear positive 913 43 (4.7) Ref Ref
 Smear negative Xpert positive 27 3 (11.1) 2.35 (0.8–7.1) 1.46 (0.4–5.1)
 Not recorded 135 12(8.9) 0.73 (0.4–1.4)  
Site of sputum microscopy
 Low volume 264 10 (3.8) Ref Ref
 Moderate volume 261 13 (4.9) 1.3 (0.6–2.9) 1.5 (0.6–3.4)
 High volume 415 23 (5.5) 1.5 (0.7–3.0) 1.6 (0.7–3.4)
  1. TB tuberculosis, RR relative risk, aRR adjusted relative risk (adjusted for age, gender, HIV status, history of TB treatment, sputum result, site of sputum microscopy), Ref reference group. Text in boldface indicates the statistical significance at p value < 0.001